| ISIN | LU2041628590 |
|---|---|
| Valorennummer | 49478901 |
| Bloomberg Global ID | |
| Fondsname | JSS Sustainable Equity - Future Health M USD acc |
| Fondsanbieter |
J. Safra Sarasin Investmentfonds AG
Basel, Schweiz Telefon: +41 58 317 44 44 Web: www.jsafrasarasin.com |
| Fondsanbieter | J. Safra Sarasin Investmentfonds AG |
| Vertreter in der Schweiz |
J. Safra Sarasin Investmentfonds AG Basel Telefon: +41 58 317 44 00 |
| Distributor(en) |
Bank J. Safra Sarasin AG Basel Telefon: +41 58 317 44 00 |
| Anlagekategorie | Aktienfonds |
| EFC-Kategorie | |
| Anteilskategorie | Accumulation |
| Domizilland | Luxemburg |
| Konditionen bei der Ausgabe | Ausgabekommission zugunsten der Fondsleitung und/oder des Vertriebsträgers (kann bei gleichem Fonds je nach Vertriebskanal unterschiedlich sein) |
| Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
| Investment-Strategie *** | The investment objective of the fund is to achieve long-term capital growth. The Reference Currency of the Sub-Fund is the US Dollar (USD). The assets of the fund are mainly invested worldwide either directly (min. 67% of the SubFund’s assets) or indirectly in equity securities that offer an exposure to one or multiple emerging and transformational health trends. The Sub-Fund invests in leading companies and niche players whose products and services contribute to the improvement of health outcome and the dampening of rising healthcare costs. |
| Besonderheiten |
| Aktueller Preis * | 103.38 USD | 29.04.2024 |
|---|---|---|
| Vorheriger Preis * | 102.98 USD | 26.04.2024 |
| 52 Wochen Hoch * | 110.74 USD | 08.05.2023 |
| 52 Wochen Tief * | 87.01 USD | 27.10.2023 |
| NAV * | 103.38 USD | 29.04.2024 |
| Ausgabepreis * | ||
| Rücknahmepreis * | ||
| Schlusskurs * | ||
| Indikativer Minimalpreis | ||
| Fondsvermögen *** | 135'372'697 | |
| Anteilsklassevermögen *** | 190'559 | |
| Trading Information SIX | ||
| YTD-Performance | - | - |
|---|---|---|
| YTD-Performance (in CHF) | - | - |
| 1 Monat | -0.04% |
02.04.2024 - 29.04.2024
02.04.2024 29.04.2024 |
| 3 Monate | +0.49% |
29.01.2024 - 29.04.2024
29.01.2024 29.04.2024 |
| 6 Monate | +18.43% |
30.10.2023 - 29.04.2024
30.10.2023 29.04.2024 |
| 1 Jahr | -4.97% |
02.05.2023 - 29.04.2024
02.05.2023 29.04.2024 |
| 2 Jahre | +3.38% |
14.09.2022 - 29.04.2024
14.09.2022 29.04.2024 |
| 3 Jahre | - | - |
| 5 Jahre | - | - |
| Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Eli Lilly and Co | 7.88% | |
|---|---|---|
| Johnson & Johnson | 6.85% | |
| Danaher Corp | 6.50% | |
| argenx SE | 5.43% | |
| Sanofi SA | 5.00% | |
| AstraZeneca PLC | 4.99% | |
| Medtronic PLC | 4.52% | |
| UnitedHealth Group Inc | 4.10% | |
| AbbVie Inc | 4.05% | |
| Gilead Sciences Inc | 3.93% | |
| Letzte Daten-Aktualisierung | 31.08.2025 | |
| TER | 0.40% |
|---|---|
| Datum TER | 31.10.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.12% |
| Ongoing Charges *** | 0.25% |
|
SRRI ***
|
|
| Datum SRRI *** | 30.04.2024 |